Assessment Of Sildenafil On Erectile Function And Intercourse Satisfaction And To Validate A New Subject Questionnaire

Completed · Phase 4 · Has a placebo group

Conditions studied: Impotence

In brief

To evaluate the effectiveness of sildenafil on erectile function and intercourse satisfaction in men with ED as well as to validate the new Sexual Experience Questionnaire which incorporates functional and emotional elements of a man's sexual experience into one comprehensive questionnaire.

Key facts

Study ID

NCT00147628

Run by

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

People needed

209

Starts

2005-11-01

Expected to finish

2006-09-01

Last updated by the study team

2021-02-01

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Documented clinical diagnosis of erectile dysfunction, defined by a score of less than or equal to 25 on the Erectile Dysfunction domain of the International Index of Erectile Function

You may not qualify if…

• Subjects who have been treated with more than 6 doses of sildenafil or any other phosphodiesterase type 5 inhibitor

Where it is running

• Pfizer Investigational Site — Huntsville, Alabama, United States
• Pfizer Investigational Site — San Diego, California, United States
• Pfizer Investigational Site — Aurora, Colorado, United States
• Pfizer Investigational Site — Miami, Florida, United States
• Pfizer Investigational Site — Ocala, Florida, United States
• Pfizer Investigational Site — Tallahassee, Florida, United States
• Pfizer Investigational Site — Jeffersonville, Indiana, United States
• Pfizer Investigational Site — Des Moines, Iowa, United States
• Pfizer Investigational Site — Shreveport, Louisiana, United States
• Pfizer Investigational Site — Las Vegas, Nevada, United States
• Pfizer Investigational Site — Garden City, New York, United States
• Pfizer Investigational Site — Kingston, New York, United States
• Pfizer Investigational Site — New York, New York, United States
• Pfizer Investigational Site — Poughkeepsie, New York, United States
• Pfizer Investigational Site — Fargo, North Dakota, United States
• Pfizer Investigational Site — Cincinnati, Ohio, United States
• Pfizer Investigational Site — Houston, Texas, United States
• Pfizer Investigational Site — San Antonio, Texas, United States
• Pfizer Investigational Site — Seattle, Washington, United States
• Pfizer Investigational Site — Spokane, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.